Series B

With its new $165M fifth fund, StageOne Ventures doubles down on Israel's AI and enterprise tech, reinforcing the nation's resilient innovation ecosystem.

In a bold move to unify robotics, Havoc is integrating sea, air, and land platforms, aiming to redefine both military strategy and heavy industry.

A new report shows Munich and Hamburg are outpacing rivals in attracting investment, leveraging online credibility as a powerful new tool on the global stage.

With its new oversubscribed fund, Scout Ventures is doubling down on veteran-led startups building the next generation of national security technology.

The private equity firm hires Laura Noisten to lead leveraged finance, a strategic move to fuel growth in the complex aerospace and defense tech sector.

Finance veteran Stephen Siderow brings institutional expertise to a burgeoning real estate tech VC, aiming to capitalize on AI-driven disruption.

As AI reshapes medicine, one veterinary firm's 'No AI' policy is earning major awards and the loyalty of the vets it serves. Here's why.

Dr. Pietro Garbelli's award-winning book offers a crucial roadmap for responsibly integrating AI, balancing high-tech innovation with patient trust.

Fueled by strong investor demand and a lead order from Purpose Global Resource Fund, Lithium Africa will acquire a key South African lithium asset.

With book value soaring, Stack Capital offers a rare public window into the massive valuations of private titans like SpaceX and the AI infrastructure boom.

With FDA Breakthrough status for its MASH drug, a new CEO, and a fortified balance sheet, Altimmune is poised to take on serious liver disease and addiction.

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

Novos Power and WearableDose win FedTech's Crucible competition, highlighting critical innovations in power grid stability and real-time radiation monitoring.

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

With 10 million users acquired organically, Presentations.AI is leading a shift from static slides to dynamic, AI-powered 'decision infrastructure'.

With its CFO at a key forum, Syntiant leverages 100M+ chip deployments to prove the value of on-device intelligence in a booming multi-billion dollar market.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

The architect of Tesla's dry electrode acquisition is back, betting on AM Batteries' DBE 2.0 to revolutionize how batteries are made. Here's why.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

With a key drug in trials and a pipeline nearing the clinic, Foghorn Therapeutics brings in a seasoned financial leader to navigate its path to market.